Sunday, June 1, 2014

New Biomarker tests for Prostate Cancer



Recently there are several new tests available for Prostrate cancer They are:

A. Tests That Improve the Accuracy of a Negative Biopsy

• Prostate Cancer Mitomic Test (PCMT)
• Confirm MDx Test

B. Tests That Improve the Accuracy of Pathologic Grading of a Positive Biopsy or Radical Prostatectomy Specimen

• OncotypeDX Test (Genomic Prostate Score)
• Prolaris Test (Score)
• Decipher Test (GenomicProstate Cancer Classifier)
• QuadVysion and ProstaVysion Tests
• OurView Prognostic Panel

C. Tests that Improve PCa Treatment Selection and Efficacy

• Caris Molecular Intelligence Profile and Profile Plus Tests



Visit the full report here:
http://prostate-cancer.org/wp-content/uploads/insights/august2013/Insights_August2013_%20New_Biomarker_Test.pdf


A summary of the new tests as reported in the New York Times:

http://www.nytimes.com/interactive/2013/03/26/business/new-ways-to-assess-prostate-cancer.html?ref=business&_r=2&



Take care

Allen Lai

No comments:

Post a Comment